Latest Filings

Issuer Activity

Insider Overview :: Microbix Biosystems Inc. (T:MBX) [?]
Business Focus: Biotechnology & Medical Research
Recent Price for MBX
CAD 0.190 -0.01 (-5.26%)
TSX Delayed 15 minutes
May 21 1000 EDT
1-Day High 52-Week High P/E 1-Day Volume Mkt Cap ($Mil)
N/A 0.400 0.0 N/A 12.67
1-Day Low 52-Week Low Yield Avg. Volume  
N/A 0.150 0.0% 11,829  
Log in or sign up for a free account to add this stock to your watch list.
Holdings trends & enhanced charts available in PDF report. Click here for details »
Latest 10 SEDI filings (by transaction date) for MBX within the last 6 months [?]
Amended Filing
As of 11:59pm ET May 21st, 2013
Filing
Date 		Transaction
Date 		Insider Name Ownership
Type 		Securities Nature of transaction # or value acquired or disposed of Price
Dec 20/12 Dec 19/12 Embro-Pantalony, Vaughn Direct Ownership Options 50 - Grant of options 400,000  
Nov 27/12 Nov 27/12 Gastle, Angus Direct Ownership Common Shares 10 - Acquisition in the public market 5,000 $0.255
Sign up for an account or login above to see all SEDI filings within the past 6 months.
Latest 10 SEDI filings (by filing date) for MBX within the last 6 months [?]
Amended Filing
As of 11:59pm ET May 21st, 2013
Filing
Date 		Transaction
Date 		Insider Name Ownership
Type 		Securities Nature of transaction # or value acquired or disposed of Price
Dec 20/12 Dec 19/12 Embro-Pantalony, Vaughn Direct Ownership Options 50 - Grant of options 400,000  
Nov 27/12 Nov 27/12 Gastle, Angus Direct Ownership Common Shares 10 - Acquisition in the public market 5,000 $0.255
Sign up for an account or login above to see all SEDI filings within the past 6 months.
Sign up for an account or login above to see the past 6 months of SEDI filings sorted by insider.
No Markers (TSX Insider Summaries) for MBX on May 21, 2013 [?]
To view marker data for the past week, sign up for an account or log in above.
To view more history, sign up for an account at inkresearch.com
Sector:  Healthcare Industry:  Biotechnology & Medical Research
Key People
William J. Gastle
Executive Chairman of the Board 		Vaughn C. Embro-Pantalony
President, Chief Executive Officer, Director 		James A. Long
Chief Financial Officer
Company Contact
Address: 265 Watline Avenue
MISSISSAUGA ON L4Z 1P3
Tel: 1-416-2341624
Website: www.microbix.com
IR: www.microbix.com/Public/Default.aspx?I=11&n=Investor+Relations
Business Overview
Microbix Biosystems Inc. (Microbix) is a Canada-based biotechnology company. Microbix is engaged in research and development, and commercialization of biological products and technologies. It commercializes technologies for influenza vaccine manufacturing. The Company's development pipeline includes Virus Yield Enhancement Technology (VIRUSMAX), LumiSort (Semen Sexing Technology) and a thrombolytic drug, Kinlytic (Urokinase). Microbix has developed two tissue versions of the Urokinase drug, which includes ThromboClear and CathClear. VIRUSMAX is engaged in the production of influenza vaccine. Microbix's Virology products business is used by multinational customers in the diagnostic industry to manufacture their finished products based on the cell culture and virology. It sells approximately 40 products to over 100 companies in the United States, Europe and Asia. In February 2013, the Company sold its Water-for-Injection business to Irvine Scientific in California.
Competitors with Recent Insider Filings
QLT (T:QLT)
EnWave (V:ENW)
iCo Therapeutics (V:ICO)
 
Microbix Biosystems Inc. Insider Report Only $20.00